QuidelOrtho
QDEL
$86.16
Share price
0.60%
Change (1 day)
-6.94%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.
QuidelOrtho (QDEL) - Total liabilities
Total liabilities on the balance sheet as of March 2023 : $3.79 B
According to QuidelOrtho's latest financial reports the company's total liabilities are $3.79 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
QuidelOrtho - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $3.92 B | 682.66% |
| 2021-12-31 | $0.50 B | -6.95% |
| 2020-12-31 | $0.53 B | 53.39% |
| 2019-12-31 | $0.35 B | -7.81% |
| 2018-12-31 | $0.38 B | -46.23% |
| 2017-12-31 | $0.70 B | 277.44% |
| 2016-12-31 | $0.18 B | -0.11% |
| 2015-12-31 | $0.18 B | -9.06% |
| 2014-12-31 | $0.20 B | 332.94% |
| 2013-12-31 | $47.7 M | 12.73% |
| 2012-12-31 | $42.31 M | -54.74% |
| 2011-12-31 | $93.5 M | -8.39% |
| 2010-12-31 | $0.10 B | 155.85% |
| 2009-12-31 | $39.89 M | 69.25% |
| 2008-12-31 | $23.57 M | -9.81% |
| 2007-12-31 | $26.13 M | 9.94% |
| 2006-12-31 | $23.77 M | -10.65% |
| 2005-12-31 | $26.6 M | 18.21% |
| 2004-12-31 | $22.5 M | -18.59% |
| 2003-12-31 | $27.64 M | 39.36% |
| 2002-12-31 | $19.83 M | -9.77% |
| 2001-12-31 | $21.98 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $52.22 B | 1,277.75% | 🇺🇸 USA |
 Becton Dickinson BDX | $28.70 B | 657.27% | 🇺🇸 USA |
 Danaher DHR | $33.55 B | 785.19% | 🇺🇸 USA |
 PerkinElmer
PKI | $6.74 B | 77.99% | 🇺🇸 USA |
 OraSure Technologies OSUR | $81.08 M | -97.86% | 🇺🇸 USA |
 Meridian Bioscience VIVO | $95.03 M | -97.49% | 🇺🇸 USA |